UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102- Hagens Berman ...Middle East

SAN FRANCISCO, June 5, 2025 /PRNewswire/ -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen securities between July 27, 2023 and May 15,...

Read More Details
Finally We wish PressBee provided you with enough information of ( UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102- Hagens Berman )

Also on site :

• Adorable Elephant Breaks Free From National Park and Heads Right to the Snack Aisle at the Grocery Store
• Chicago Forecast: Pleasant temperatures, mostly cloudy skies ahead of possible evening rain
• Yemen’s al-Qaida branch leader threatens Trump, Musk and others